BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee HS, Lee HK, Kim HS, Yang H, Kim WH. Tumour suppressor gene expression correlates with gastric cancer prognosis. J Pathol 2003;200:39-46. [DOI: 10.1002/path.1288] [Cited by in Crossref: 126] [Cited by in F6Publishing: 126] [Article Influence: 6.6] [Reference Citation Analysis]
Number Citing Articles
1 Tsutsui S, Inoue H, Yasuda K, Suzuki K, Higashi H, Era S, Mori M. Reduced Expression of PTEN Protein and Its Prognostic Implications in Invasive Ductal Carcinoma of the Breast. Oncology 2005;68:398-404. [DOI: 10.1159/000086981] [Cited by in Crossref: 72] [Cited by in F6Publishing: 63] [Article Influence: 4.2] [Reference Citation Analysis]
2 Chung JY, Hong SM, Choi BY, Cho H, Yu E, Hewitt SM. The expression of phospho-AKT, phospho-mTOR, and PTEN in extrahepatic cholangiocarcinoma. Clin Cancer Res 2009;15:660-7. [PMID: 19147772 DOI: 10.1158/1078-0432.CCR-08-1084] [Cited by in Crossref: 84] [Cited by in F6Publishing: 52] [Article Influence: 6.5] [Reference Citation Analysis]
3 Chang HJ, Yoo BC, Kim SW, Lee BL, Kim WH. Significance of PML and p53 protein as molecular prognostic markers of gallbladder carcinomas. Pathol Oncol Res. 2007;13:326-335. [PMID: 18158568 DOI: 10.1007/bf02940312] [Cited by in Crossref: 30] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
4 Jung IM, Chung JK, Kim YA, Kim JE, Heo SC, Ahn YJ, Hwang KT, Kim BG, Lee KL, Kim CW, Kim WH, Chang MS. Epstein-Barr virus, beta-catenin, and E-cadherin in gastric carcinomas. J Korean Med Sci 2007;22:855-61. [PMID: 17982235 DOI: 10.3346/jkms.2007.22.5.855] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
5 Hwang JH, Lee SH, Lee KH, Lee KY, Kim H, Ryu JK, Yoon YB, Kim YT. Cathepsin B is a target of Hedgehog signaling in pancreatic cancer. Cancer Lett 2009;273:266-72. [PMID: 19004543 DOI: 10.1016/j.canlet.2008.08.028] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
6 Zhao P, Liu W, Lu YL. Clinicopathological significance of FHIT protein expression in gastric adenocarcinoma patients. World J Gastroenterol 2005; 11(36): 5735-5738 [PMID: 16237777 DOI: 10.3748/wjg.v11.i36.5735] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
7 Huang Y, Chen Y, Lin X, Lin Q, Han M, Guo G. Clinical significance of SLP-2 in hepatocellular carcinoma tissues and its regulation in cancer cell proliferation, migration, and EMT. Onco Targets Ther 2017;10:4665-73. [PMID: 29033585 DOI: 10.2147/OTT.S144638] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
8 Liu D, Zhang L, Shen Z, Tan F, Hu Y, Yu J, Li G. Increased levels of SLP-2 correlate with poor prognosis in gastric cancer. Gastric Cancer. 2013;16:498-504. [PMID: 23371255 DOI: 10.1007/s10120-013-0232-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
9 Yoon TM, Kim SA, Lee JK, Park YL, Kim GY, Joo YE, Lee JH, Kim KK, Lim SC. Expression of KITENIN and its association with tumor progression in oral squamous cell carcinoma. Auris Nasus Larynx 2013;40:222-6. [PMID: 22840317 DOI: 10.1016/j.anl.2012.07.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
10 Lee EC, Yang JY, Lee KG, Oh SY, Suh YS, Kong SH, Yang HK, Lee HJ. The value of postoperative serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for the early detection of gastric cancer recurrence after curative resection. J Gastric Cancer 2014;14:221-8. [PMID: 25580353 DOI: 10.5230/jgc.2014.14.4.221] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
11 Tänzer M, Liebl M, Quante M. Molecular biomarkers in esophageal, gastric, and colorectal adenocarcinoma. Pharmacol Ther. 2013;140:133-147. [PMID: 23791941 DOI: 10.1016/j.pharmthera.2013.06.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
12 Jee CD, Kim MA, Jung EJ, Kim J, Kim WH. Identification of genes epigenetically silenced by CpG methylation in human gastric carcinoma. European Journal of Cancer 2009;45:1282-93. [DOI: 10.1016/j.ejca.2008.12.027] [Cited by in Crossref: 61] [Cited by in F6Publishing: 67] [Article Influence: 4.7] [Reference Citation Analysis]
13 Ma J, Ma J, Meng Q, Zhao ZS, Xu WJ. Prognostic value and clinical pathology of MACC-1 and c-MET expression in gastric carcinoma. Pathol Oncol Res. 2013;19:821-832. [PMID: 23812675 DOI: 10.1007/s12253-013-9650-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
14 Xiong CL, Huang Y. Advances in biological characteristics of p53 gene and its role in gastrointestinal tumors. Shijie Huaren Xiaohua Zazhi 2008; 16(32): 3648-3653 [DOI: 10.11569/wcjd.v16.i32.3648] [Reference Citation Analysis]
15 Petrelli F, Berenato R, Turati L, Mennitto A, Steccanella F, Caporale M, Dallera P, de Braud F, Pezzica E, Di Bartolomeo M, Sgroi G, Mazzaferro V, Pietrantonio F, Barni S. Prognostic value of diffuse vs intestinal histotype in patients with gastric cancer: a systematic review and meta-analysis. J Gastrointest Oncol. 2017;8:148-163. [PMID: 28280619 DOI: 10.21037/jgo.2017.01.10] [Cited by in Crossref: 40] [Cited by in F6Publishing: 45] [Article Influence: 8.0] [Reference Citation Analysis]
16 Zhao ZS, Chu YQ, Ye ZY, Wang YY, Tao HQ. Overexpression of matrix metalloproteinase 11 in human gastric carcinoma and its clinicopathologic significance. Hum Pathol 2010;41:686-96. [PMID: 20060156 DOI: 10.1016/j.humpath.2009.10.010] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
17 Lim B, Park JL, Kim HJ, Park YK, Kim JH, Sohn HA, Noh SM, Song KS, Kim WH, Kim YS. Integrative genomics analysis reveals the multilevel dysregulation and oncogenic characteristics of TEAD4 in gastric cancer. Carcinogenesis. 2014;35:1020-1027. [PMID: 24325916 DOI: 10.1093/carcin/bgt409] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 6.0] [Reference Citation Analysis]
18 Zhang J, Jin Y, Xu S, Zheng J, Zhang QI, Wang Y, Chen J, Huang Y, He X, Zhao Z. AGR2 is associated with gastric cancer progression and poor survival. Oncol Lett 2016;11:2075-83. [PMID: 26998125 DOI: 10.3892/ol.2016.4160] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
19 Oue N, Mitani Y, Motoshita J, Matsumura S, Yoshida K, Kuniyasu H, Nakayama H, Yasui W. Accumulation of DNA methylation is associated with tumor stage in gastric cancer. Cancer. 2006;106:1250-1259. [PMID: 16475210 DOI: 10.1002/cncr.21754] [Cited by in Crossref: 99] [Cited by in F6Publishing: 93] [Article Influence: 6.2] [Reference Citation Analysis]
20 Koh J, Lee KW, Nam SK, Seo AN, Kim JW, Kim JW, Park DJ, Kim HH, Kim WH, Lee HS. Development and Validation of an Easy-to-Implement, Practical Algorithm for the Identification of Molecular Subtypes of Gastric Cancer: Prognostic and Therapeutic Implications. Oncologist 2019;24:e1321-30. [PMID: 31371521 DOI: 10.1634/theoncologist.2019-0058] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
21 Kim MA, Lee HS, Yang HK, Kim WH. Clinicopa-thologic and protein expression differences between cardia carcinoma and noncardia carcinoma of the stomach. Cancer. 2005;103:1439-1446. [PMID: 15726543 DOI: 10.1002/cncr.20966] [Cited by in Crossref: 46] [Cited by in F6Publishing: 53] [Article Influence: 2.7] [Reference Citation Analysis]
22 Kim JH, Kim MK, Lee HE, Cho SJ, Cho YJ, Lee BL, Lee HS, Nam SY, Lee JS, Kim WH. Constitutive phosphorylation of the FOXO1A transcription factor as a prognostic variable in gastric cancer. Mod Pathol 2007;20:835-42. [PMID: 17491598 DOI: 10.1038/modpathol.3800789] [Cited by in Crossref: 30] [Cited by in F6Publishing: 36] [Article Influence: 2.0] [Reference Citation Analysis]
23 Jiang SB, He XJ, Xia YJ, Hu WJ, Luo JG, Zhang J, Tao HQ. MicroRNA-145-5p inhibits gastric cancer invasiveness through targeting N-cadherin and ZEB2 to suppress epithelial-mesenchymal transition. Onco Targets Ther 2016;9:2305-15. [PMID: 27143926 DOI: 10.2147/OTT.S101853] [Cited by in Crossref: 9] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
24 Lee KB, Park DJ, Choe G, Kim HH, Kim WH, Lee HS. Protein expression status in mucosal and submucosal portions of early gastric cancers and their predictive value for lymph node metastasis. APMIS 2013;121:926-37. [PMID: 23758612 DOI: 10.1111/apm.12119] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
25 Ru GQ, Wang HJ, Xu WJ, Zhao ZS. Upregulation of Twist in gastric carcinoma associated with tumor invasion and poor prognosis. Pathol Oncol Res. 2011;17:341-347. [PMID: 21104359 DOI: 10.1007/s12253-010-9332-0.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Cho YJ, Kim JH, Yoon J, Cho SJ, Ko YS, Park JW, Lee HS, Lee HE, Kim WH, Lee BL. Constitutive activation of glycogen synthase kinase-3beta correlates with better prognosis and cyclin-dependent kinase inhibitors in human gastric cancer. BMC Gastroenterol. 2010;10:91. [PMID: 20704706 DOI: 10.1186/1471-230X-10-91] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
27 Si SH, Yang JM, Peng ZH, Luo YH, Zhou P. Effects of KAI1 gene on growth and invasion of human hepatocellular carcinoma MHCC97-H cells. World J Gastroenterol 2004; 10(14): 2019-2023 [PMID: 15237426 DOI: 10.3748/wjg.v10.i14.2019] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
28 Chung Y, Wi YC, Kim Y, Bang SS, Yang JH, Jang K, Min KW, Paik SS. The Smad4/PTEN Expression Pattern Predicts Clinical Outcomes in Colorectal Adenocarcinoma. J Pathol Transl Med 2018;52:37-44. [PMID: 29056035 DOI: 10.4132/jptm.2017.10.20] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
29 Kim YJ, Kim MA, Im SA, Kim TM, Kim DW, Yang HK, Heo DS, Lee KU, Choe KJ, Kim NK. Metastasis-associated protein S100A4 and p53 predict relapse in curatively resected stage III and IV (M0) gastric cancer. Cancer Invest. 2008;26:152-158. [PMID: 18259945 DOI: 10.1080/07357900701518909] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
30 Guo CY, Xu XF, Wu JY, Liu SF. PCR-SSCP-DNA sequencing method in detecting PTEN gene mutation and its significance in human gastric cancer. World J Gastroenterol 2008; 14(24): 3804-3811 [PMID: 18609703 DOI: 10.3748/wjg.14.3804] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
31 Nam KH, Kim MA, Choe G, Kim WH, Lee HS. Deregulation of the cell polarity protein Lethal giant larvae 2 (Lgl2) correlates with gastric cancer progression. Gastric Cancer 2014;17:610-20. [PMID: 24337435 DOI: 10.1007/s10120-013-0324-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
32 Mizoshita T, Tsukamoto T, Nakanishi H, Inada K, Ogasawara N, Joh T, Itoh M, Yamamura Y, Tatematsu M. Expression of Cdx2 and the phenotype of advanced gastric cancers: relationship with prognosis. J Cancer Res Clin Oncol. 2003;129:727-734. [PMID: 14557879 DOI: 10.1007/s00432-003-0499-6] [Cited by in Crossref: 99] [Cited by in F6Publishing: 92] [Article Influence: 5.2] [Reference Citation Analysis]
33 Traylor RN, Fan Z, Hudson B, Rosenfeld JA, Shaffer LG, Torchia BS, Ballif BC. Microdeletion of 6q16.1 encompassing EPHA7 in a child with mild neurological abnormalities and dysmorphic features: case report. Mol Cytogenet 2009;2:17. [PMID: 19664229 DOI: 10.1186/1755-8166-2-17] [Cited by in Crossref: 52] [Cited by in F6Publishing: 55] [Article Influence: 4.0] [Reference Citation Analysis]
34 Jiang PH, Motoo Y, Garcia S, Iovanna JL, Pébusque MJ, Sawabu N. Down-expression of tumor protein p53-induced nuclear protein 1 in human gastric cancer. World J Gastroenterol 2006; 12(5): 691-696 [PMID: 16521180 DOI: 10.3748/wjg.v12.i5.691] [Cited by in CrossRef: 52] [Cited by in F6Publishing: 52] [Article Influence: 3.3] [Reference Citation Analysis]
35 Lee HS, Kim WH. Tissue array methods for high-throughput clinicopathologic research. Cancer Res Treat 2006;38:1-6. [PMID: 19771251 DOI: 10.4143/crt.2006.38.1.1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
36 Guo J, Fan KX, Xie LI, Xiao JJ, Chen K, Hui LN, Xu ZF. Effect and prognostic significance of the KAI1 gene in human gastric carcinoma. Oncol Lett 2015;10:2035-42. [PMID: 26622792 DOI: 10.3892/ol.2015.3604] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
37 van Nederveen FH, Perren A, Dannenberg H, Petri BJ, Dinjens WN, Komminoth P, de Krijger RR. PTEN gene loss, but not mutation, in benign and malignant phaeochromocytomas. J Pathol 2006;209:274-80. [PMID: 16538614 DOI: 10.1002/path.1968] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
38 Sung JY, Park SY, Kim JH, Kang HG, Yoon JH, Na YS, Kim YN, Park BK. Interferon consensus sequence-binding protein (ICSBP) promotes epithelial-to-mesenchymal transition (EMT)-like phenomena, cell-motility, and invasion via TGF-β signaling in U2OS cells. Cell Death Dis 2014;5:e1224. [PMID: 24832596 DOI: 10.1038/cddis.2014.189] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
39 Griffiths EA, Pritchard SA, Welch IM, Price PM, West CM. Is the hypoxia-inducible factor pathway important in gastric cancer? Eur J Cancer. 2005;41:2792-2805. [PMID: 16290133 DOI: 10.1016/j.ejca.2005.09.008] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 3.2] [Reference Citation Analysis]
40 Giannakis M, Bäckhed HK, Chen SL, Faith JJ, Wu M, Guruge JL, Engstrand L, Gordon JI. Response of gastric epithelial progenitors to Helicobacter pylori Isolates obtained from Swedish patients with chronic atrophic gastritis. J Biol Chem. 2009;284:30383-30394. [PMID: 19723631 DOI: 10.1074/jbc.m109.052738] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
41 Kageyama-Yahara N, Yamamichi N, Takahashi Y, Nakayama C, Shiogama K, Inada K, Konno-Shimizu M, Kodashima S, Fujishiro M, Tsutsumi Y, Ichinose M, Koike K. Gli regulates MUC5AC transcription in human gastrointestinal cells. PLoS One 2014;9:e106106. [PMID: 25166306 DOI: 10.1371/journal.pone.0106106] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
42 Lai CK, Lu YL, Hsieh JT, Tsai SC, Feng CL, Tsai YS, Tsai PC, Su HL, Lin YH, Lai CH. Development of chitosan/heparin nanoparticle-encapsulated cytolethal distending toxin for gastric cancer therapy. Nanomedicine (Lond) 2014;9:803-17. [PMID: 24024568 DOI: 10.2217/nnm.13.54] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
43 Qian J, Qian Y, Wang J, Gu B, Pei D, He S, Zhu F, Røe OD, Xu J, Liu L, Gu Y, Guo R, Yin Y, Shu Y, Chen X. A clinical prognostic scoring system for resectable gastric cancer to predict survival and benefit from paclitaxel- or oxaliplatin-based adjuvant chemotherapy. Drug Des Devel Ther 2016;10:241-58. [PMID: 26966350 DOI: 10.2147/DDDT.S88743] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
44 Ru GQ, Wang HJ, Xu WJ, Zhao ZS. Upregulation of Twist in gastric carcinoma associated with tumor invasion and poor prognosis. Pathol Oncol Res. 2011;17:341-347. [PMID: 21104359 DOI: 10.1007/s12253-010-9332-0] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 3.0] [Reference Citation Analysis]
45 Lee HE, Smyrk TC, Zhang L. Histologic and immunohistochemical differences between hereditary and sporadic diffuse gastric carcinoma. Hum Pathol 2018;74:64-72. [PMID: 29307626 DOI: 10.1016/j.humpath.2017.12.023] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
46 Wang HL, Zhou PY, Liu P, Zhang Y. Abnormal FHIT protein expression may be correlated with poor prognosis in gastric cancer: a meta-analysis. Tumour Biol 2014;35:6815-21. [PMID: 24729090 DOI: 10.1007/s13277-014-1936-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
47 Kubota E, Kataoka H, Aoyama M, Mizoshita T, Mori Y, Shimura T, Tanaka M, Sasaki M, Takahashi S, Asai K. Role of ES cell-expressed Ras (ERas) in tumorigenicity of gastric cancer. Am J Pathol. 2010;177:955-963. [PMID: 20566745 DOI: 10.2353/ajpath.2010.091056] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
48 Hissong E, Ramrattan G, Zhang P, Zhou XK, Young G, Klimstra DS, Shia J, Fernandes H, Yantiss RK. Gastric Carcinomas With Lymphoid Stroma: An Evaluation of the Histopathologic and Molecular Features. Am J Surg Pathol. 2018;42:453-462. [PMID: 29438172 DOI: 10.1097/pas.0000000000001018] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 5.7] [Reference Citation Analysis]
49 Zheng HC, Liu LL. FHIT down-regulation was inversely linked to aggressive behaviors and adverse prognosis of gastric cancer: a meta- and bioinformatics analysis. Oncotarget 2017;8:108261-73. [PMID: 29296239 DOI: 10.18632/oncotarget.22369] [Reference Citation Analysis]
50 Tonini T, D’Andrilli G, Fucito A, Gaspa L, Bagella L. Importance of Ezh2 polycomb protein in tumorigenesis process interfering with the pathway of growth suppressive key elements. J Cell Physiol. 2008;214:295-300. [PMID: 17786943 DOI: 10.1002/jcp.21241] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 3.4] [Reference Citation Analysis]
51 Choi Y, Park J, Choi Y, Ko YS, Yu DA, Kim Y, Pyo JS, Jang BG, Kim MA, Kim WH. c-Jun N-terminal kinase activation has a prognostic implication and is negatively associated with FOXO1 activation in gastric cancer. BMC Gastroenterol. 2016;16:59. [PMID: 27268017 DOI: 10.1186/s12876-016-0473-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
52 Kordi Tamandani DM, Hemati S, Davani SK, Arbabi F. Association between promoter methylation and expression of thyroid hormone receptor beta ( THRβ ) gene in patients with gastric cancer in an Iranian population: Promoter methylation and THRβ expression. J Gastroenterol Hepatol 2015;30:485-9. [DOI: 10.1111/jgh.12808] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
53 Yoon J, Cho SJ, Ko YS, Park J, Shin DH, Hwang IC, Han SY, Nam SY, Kim MA, Chang MS, Lee HS, Kim WH, Lee BL. A synergistic interaction between transcription factors nuclear factor-κB and signal transducers and activators of transcription 3 promotes gastric cancer cell migration and invasion. BMC Gastroenterol 2013;13:29. [PMID: 23402362 DOI: 10.1186/1471-230X-13-29] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
54 Li HS, Liu X, Zhang MY, Cheng K, Chen Y, Zhou YW, Liu JY. Clinicopathologic characteristics, survival, and treatments for gastric adenosquamous carcinoma: a population-based study. Curr Oncol 2020;27:e527-36. [PMID: 33380867 DOI: 10.3747/co.27.6337] [Reference Citation Analysis]
55 Yu D, Yoon J, Ko YS, Park J, Kim SY, Kim MA, Kim JH, Jung J, Cheon Y, Lee HS, Kim WH, Lee BL. Forkhead transcription factor FOXO1 inhibits nuclear factor-κB in gastric cancer. APMIS 2014;122:848-55. [DOI: 10.1111/apm.12247] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
56 Choi Y, Ko YS, Park J, Choi Y, Kim Y, Pyo JS, Jang BG, Hwang DH, Kim WH, Lee BL. HER2-induced metastasis is mediated by AKT/JNK/EMT signaling pathway in gastric cancer. World J Gastroenterol 2016; 22(41): 9141-9153 [PMID: 27895401 DOI: 10.3748/wjg.v22.i41.9141] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
57 Kawano M, Tanaka K, Itonaga I, Ikeda S, Iwasaki T, Tsumura H. microRNA-93 promotes cell proliferation via targeting of PTEN in Osteosarcoma cells. J Exp Clin Cancer Res 2015;34:76. [PMID: 26243299 DOI: 10.1186/s13046-015-0192-z] [Cited by in Crossref: 44] [Cited by in F6Publishing: 49] [Article Influence: 6.3] [Reference Citation Analysis]
58 Zhou YJ, Xiong YX, Wu XT, Shi D, Fan W, Zhou T, Li YC, Huang X. Inactivation of PTEN is associated with increased angiogenesis and VEGF overexpression in gastric cancer. World J Gastroenterol 2004; 10(21): 3225-3229 [PMID: 15457582 DOI: 10.3748/wjg.v10.i21.3225] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.4] [Reference Citation Analysis]
59 Jia SQ, Niu ZJ, Zhang LH, Zhong XY, Shi T, Du H, Zhang GG, Hu Y, Su XL, Ji JF. Identification of prognosis-related proteins in advanced gastric cancer by mass spectrometry-based comparative proteomics. J Cancer Res Clin Oncol. 2009;135:403-411. [PMID: 18830628 DOI: 10.1007/s00432-008-0474-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
60 Nam SY, Lee HS, Jung GA, Choi J, Cho SJ, Kim MK, Kim WH, Lee BL. Akt/PKB activation in gastric carcinomas correlates with clinicopathologic variables and prognosis. APMIS. 2003;111:1105-1113. [PMID: 14678019 DOI: 10.1111/j.1600-0463.2003.apm1111205.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 66] [Article Influence: 3.5] [Reference Citation Analysis]
61 Thuwajit P, Chawengrattanachot W, Thuwajit C, Sripa B, Paupairoj A, Chau-In S. Enhanced expression of mucin 6 glycoprotein in cholangiocarcinoma tissue from patients in Thailand as a prognostic marker for survival. J Gastroenterol Hepatol 2008;23:771-8. [PMID: 18410610 DOI: 10.1111/j.1440-1746.2008.05332.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
62 Ghatak S, Chakraborty P, Sarkar SR, Chowdhury B, Bhaumik A, Kumar NS. Novel APC gene mutations associated with protein alteration in diffuse type gastric cancer. BMC Med Genet. 2017;18:61. [PMID: 28576136 DOI: 10.1186/s12881-017-0427-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
63 Thanapprapasr D, Previs RA, Hu W, Ivan C, Armaiz-Pena GN, Dorniak PL, Hansen JM, Rupaimoole R, Huang J, Dalton HJ, Ali-Fehmi R, Coleman RL, Sood AK. PTEN Expression as a Predictor of Response to Focal Adhesion Kinase Inhibition in Uterine Cancer. Mol Cancer Ther 2015;14:1466-75. [PMID: 25833835 DOI: 10.1158/1535-7163.MCT-14-1077] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
64 Yang Q, Ye Z, Zhang Q, Zhao Z, Yuan H. Expression of eukaryotic translation initiation factor 5A-2 (eIF5A-2) associated with poor survival in gastric cancer. Tumour Biol. 2016;37:1189-1195. [PMID: 26282002 DOI: 10.1007/s13277-015-3894-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
65 Kurashige J, Kamohara H, Watanabe M, Hiyoshi Y, Iwatsuki M, Tanaka Y, Kinoshita K, Saito S, Baba Y, Baba H. MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma. Ann Surg Oncol. 2012;19 Suppl 3:S656-S664. [PMID: 22311119 DOI: 10.1245/s10434-012-2217-6] [Cited by in Crossref: 115] [Cited by in F6Publishing: 118] [Article Influence: 11.5] [Reference Citation Analysis]
66 Mattar R, Nonogaki S, Silva C, Alves V, Gama-Rodrigues JJ. P53 and Rb tumor suppressor gene alterations in gastric cancer. Rev Hosp Clin Fac Med Sao Paulo 2004;59:172-80. [PMID: 15361981 DOI: 10.1590/s0041-87812004000400004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
67 Kim MA, Lee HS, Lee HE, Kim JH, Yang HK, Kim WH. Prognostic importance of epithelial-mesenchymal transition-related protein expression in gastric carcinoma. Histopathology. 2009;54:442-451. [PMID: 19309396 DOI: 10.1111/j.1365-2559.2009.03247.x] [Cited by in Crossref: 95] [Cited by in F6Publishing: 95] [Article Influence: 7.3] [Reference Citation Analysis]
68 Yang Z, Lv NH. Role of PTEN in gastric carcinogenesis. Shijie Huaren Xiaohua Zazhi 2011; 19(6): 608-613 [DOI: 10.11569/wcjd.v19.i6.608] [Reference Citation Analysis]
69 Kim YH, Lee HS, Lee HJ, Hur K, Kim WH, Bang YJ, Kim SJ, Lee KU, Choe KJ, Yang HK. Prognostic significance of the expression of Smad4 and Smad7 in human gastric carcinomas. Ann Oncol. 2004;15:574-580. [PMID: 15033661 DOI: 10.1093/annonc/mdh131] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 2.4] [Reference Citation Analysis]
70 Pinto RP, Lima FK, Kulkzynski JM, Moreira LF. Expression of P16 and PDGFR-beta in gastric adenocarcinoma. Rev Col Bras Cir 2009;36:199-203. [PMID: 20076898 DOI: 10.1590/s0100-69912009000300004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
71 Li L, Wang YY, Zhao ZS, Ma J. Ezrin is associated with gastric cancer progression and prognosis. Pathol Oncol Res. 2011;17:909-915. [PMID: 21717114 DOI: 10.1007/s12253-011-9402-y] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
72 Bepler G, Sharma S, Cantor A, Gautam A, Haura E, Simon G, Sharma A, Sommers E, Robinson L. RRM1 and PTEN as prognostic parameters for overall and disease-free survival in patients with non-small-cell lung cancer. J Clin Oncol 2004;22:1878-85. [PMID: 15143080 DOI: 10.1200/JCO.2004.12.002] [Cited by in Crossref: 141] [Cited by in F6Publishing: 65] [Article Influence: 7.8] [Reference Citation Analysis]
73 Wang YY, Ye ZY, Li L, Zhao ZS, Shao QS, Tao HQ. ADAM 10 is associated with gastric cancer progression and prognosis of patients. J Surg Oncol. 2011;103:116-123. [PMID: 21259244 DOI: 10.1002/jso.21781] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
74 Lee JH, Sung JY, Choi EK, Yoon HK, Kang BR, Hong EK, Park BK, Kim YN, Rho SB, Yoon K. C/EBPβ Is a Transcriptional Regulator of Wee1 at the G₂/M Phase of the Cell Cycle. Cells 2019;8:E145. [PMID: 30754676 DOI: 10.3390/cells8020145] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
75 Luo ZY, Wang YY, Zhao ZS, Li B, Chen JF. The expression of TMPRSS4 and Erk1 correlates with metastasis and poor prognosis in Chinese patients with gastric cancer. PLoS One 2013;8:e70311. [PMID: 23922976 DOI: 10.1371/journal.pone.0070311] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
76 Novotny AR, Schuhmacher C, Busch R, Kattan MW, Brennan MF, Siewert JR. Predicting individual survival after gastric cancer resection: validation of a U.S.-derived nomogram at a single high-volume center in Europe. Ann Surg 2006;243:74-81. [PMID: 16371739 DOI: 10.1097/01.sla.0000194088.81126.85] [Cited by in Crossref: 73] [Cited by in F6Publishing: 69] [Article Influence: 4.6] [Reference Citation Analysis]
77 Na HY, Park Y, Nam SK, Koh J, Kwak Y, Ahn S, Park DJ, Kim H, Lee KS, Lee HS. Prognostic significance of natural killer cell-associated markers in gastric cancer: quantitative analysis using multiplex immunohistochemistry. J Transl Med 2021;19. [DOI: 10.1186/s12967-021-03203-8] [Reference Citation Analysis]
78 Bragantini E, Barbi S, Beghelli S, Moore PS, de Manzoni G, Roviello F, Tomezzoli A, Vindigni C, Baffa R, Scarpa A. Loss of Fhit expression is associated with poorer survival in gastric cancer but is not an independent prognostic marker. J Cancer Res Clin Oncol. 2006;132:45-50. [PMID: 16217683 DOI: 10.1007/s00432-005-0045-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
79 Darwish NS, Kim MA, Chang MS, Lee HS, Lee BL, Kim YI, Kim WH. Prognostic significance of CD24 expression in gastric carcinoma. Cancer Res Treat. 2004;36:298-302. [PMID: 20368819 DOI: 10.4143/crt.2004.36.5.298] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 1.2] [Reference Citation Analysis]
80 Jin C, Wang A, Chen J, Liu X, Wang G. Relationship between expression and prognostic ability of PTEN, STAT3 and VEGF-C in colorectal cancer. Exp Ther Med 2012;4:633-9. [PMID: 23170117 DOI: 10.3892/etm.2012.651] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
81 Ho CM, Lin MC, Huang SH, Huang CJ, Lai HC, Chien TY, Chang SF. PTEN promoter methylation and LOH of 10q22-23 locus in PTEN expression of ovarian clear cell adenocarcinomas. Gynecol Oncol 2009;112:307-13. [PMID: 19007975 DOI: 10.1016/j.ygyno.2008.09.040] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
82 Kim SY, Yoon J, Ko YS, Chang MS, Park JW, Lee HE, Kim MA, Kim JH, Kim WH, Lee BL. Constitutive phosphorylation of the FOXO1 transcription factor in gastric cancer cells correlates with microvessel area and the expressions of angiogenesis-related molecules. BMC Cancer. 2011;11:264. [PMID: 21696576 DOI: 10.1186/1471-2407-11-264] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 3.0] [Reference Citation Analysis]
83 Kosari‐monfared M, Nikbakhsh N, Fattahi S, Ghadami E, Ranaei M, Taheri H, Amjadi‐moheb F, Godazandeh GA, Shafaei S, Pilehchian‐langroudi M, Samadani AA, Akhavan‐niaki H. CTNNBIP1 downregulation is associated with tumor grade and viral infections in gastric adenocarcinoma. J Cell Physiol 2018;234:2895-904. [DOI: 10.1002/jcp.27106] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
84 Parsons R. Human cancer, PTEN and the PI-3 kinase pathway. Semin Cell Dev Biol. 2004;15:171-176. [PMID: 15209376 DOI: 10.1016/j.semcdb.2003.12.021] [Cited by in Crossref: 153] [Cited by in F6Publishing: 143] [Article Influence: 8.5] [Reference Citation Analysis]
85 Deng Y, Cai S, Shen J, Peng H. Tetraspanins: Novel Molecular Regulators of Gastric Cancer. Front Oncol 2021;11:702510. [PMID: 34222025 DOI: 10.3389/fonc.2021.702510] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
86 Yu G, Fang W, Xia T, Chen Y, Gao Y, Jiao X, Huang S, Wang J, Li Z, Xie K. Metformin potentiates rapamycin and cisplatin in gastric cancer in mice. Oncotarget. 2015;6:12748-12762. [PMID: 25909163 DOI: 10.18632/oncotarget.3327] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 7.7] [Reference Citation Analysis]
87 Semba S, Satake S, Matsushita M, Yokozaki H. Phosphatase activity of nuclear PTEN is required for CDX2-mediated intestinal differentiation of gastric carcinoma. Cancer Lett. 2009;274:143-150. [PMID: 18996641 DOI: 10.1016/j.canlet.2008.09.019] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
88 Kim MA, Lee HE, Lee HS, Yang HK, Kim WH. Expression of apoptosis-related proteins and its clinical implication in surgically resected gastric carcinoma. Virchows Arch 2011;459:503-10. [PMID: 21947931 DOI: 10.1007/s00428-011-1150-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
89 Ghasabi M, Majidi J, Mansoori B, Mohammadi A, Shomali N, Shirafkan N, Baghbani E, Kazemi T, Baradaran B. The effect of combined miR‐200c replacement and cisplatin on apoptosis induction and inhibition of gastric cancer cell line migration. J Cell Physiol 2019;234:22581-92. [DOI: 10.1002/jcp.28823] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
90 Wang YY, Ye ZY, Zhao ZS, Tao HQ, Chu YQ. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer. Ann Surg Oncol 2010;17:89-97. [PMID: 19820999 DOI: 10.1245/s10434-009-0722-z] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
91 Guo SL, Ye H, Teng Y, Wang YL, Yang G, Li XB, Zhang C, Yang X, Yang ZZ, Yang X. Akt-p53-miR-365-cyclin D1/cdc25A axis contributes to gastric tumorigenesis induced by PTEN deficiency. Nat Commun. 2013;4:2544. [PMID: 24149576 DOI: 10.1038/ncomms3544] [Cited by in Crossref: 64] [Cited by in F6Publishing: 72] [Article Influence: 8.0] [Reference Citation Analysis]
92 Kim JH, Kim MA, Lee HS, Kim WH. Comparative analysis of protein expressions in primary and metastatic gastric carcinomas. Hum Pathol 2009;40:314-22. [PMID: 18835621 DOI: 10.1016/j.humpath.2008.07.013] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 2.4] [Reference Citation Analysis]
93 Kim SY, Ko YS, Park J, Choi Y, Park JW, Kim Y, Pyo JS, Yoo YB, Lee JS, Lee BL. Forkhead Transcription Factor FOXO1 Inhibits Angiogenesis in Gastric Cancer in Relation to SIRT1. Cancer Res Treat 2016;48:345-54. [PMID: 25761483 DOI: 10.4143/crt.2014.247] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
94 Teramoto K, Tada M, Tamoto E, Abe M, Kawakami A, Komuro K, Matsunaga A, Shindoh G, Takada M, Murakawa K, Kanai M, Kobayashi N, Fujiwara Y, Nishimura N, Shirata K, Takahishi T, Ishizu A, Ikeda H, Hamada J, Kondo S, Katoh H, Moriuchi T, Yoshiki T. Prediction of lymphatic invasion/lymph node metastasis, recurrence, and survival in patients with gastric cancer by cDNA array-based expression profiling. J Surg Res 2005;124:225-36. [PMID: 15820252 DOI: 10.1016/j.jss.2004.10.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
95 Nobili S, Bruno L, Landini I, Napoli C, Bechi P, Tonelli F, Rubio CA, Mini E, Nesi G. Genomic and genetic alterations influence the progression of gastric cancer. World J Gastroenterol 2011; 17(3): 290-299 [PMID: 21253387 DOI: 10.3748/wjg.v17.i3.290] [Cited by in CrossRef: 74] [Cited by in F6Publishing: 73] [Article Influence: 6.7] [Reference Citation Analysis]
96 Fuereder T, Jaeger-Lansky A, Hoeflmayer D, Preusser M, Strommer S, Cejka D, Koehrer S, Crevenna R, Wacheck V. mTOR inhibition by everolimus counteracts VEGF induction by sunitinib and improves anti-tumor activity against gastric cancer in vivo. Cancer Lett 2010;296:249-56. [PMID: 20471160 DOI: 10.1016/j.canlet.2010.04.015] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
97 Li W, Chen Y, Sun X, Yang J, Zhang DY, Wang D, Suo J. Protein expression profiles and clinicopathologic characteristics associate with gastric cancer survival. Biol Res 2019;52:42. [PMID: 31399040 DOI: 10.1186/s40659-019-0249-0] [Reference Citation Analysis]
98 Zhao LJ, Liu XG, Liu YZ, Liu YJ, Papasian CJ, Sha BY, Pan F, Guo YF, Wang L, Yan H, Xiong DH, Tang ZH, Yang TL, Chen XD, Guo Y, Li J, Shen H, Zhang F, Lei SF, Recker RR, Deng HW. Genome-wide association study for femoral neck bone geometry. J Bone Miner Res 2010;25:320-9. [PMID: 20175129 DOI: 10.1359/jbmr.090726] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
99 Giannakis M, Chen SL, Karam SM, Engstrand L, Gordon JI. Helicobacter pylori evolution during progression from chronic atrophic gastritis to gastric cancer and its impact on gastric stem cells. Proc Natl Acad Sci USA. 2008;105:4358-4363. [PMID: 18332421 DOI: 10.1073/pnas.0800668105] [Cited by in Crossref: 76] [Cited by in F6Publishing: 72] [Article Influence: 5.4] [Reference Citation Analysis]
100 Ghosh M, Sakhuja P, Singh S, Agarwal AK. p53 and beta-catenin expression in gallbladder tissues and correlation with tumor progression in gallbladder cancer. Saudi J Gastroenterol. 2013;19:34-39. [PMID: 23319036 DOI: 10.4103/1319-3767.105922] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
101 Cho Y, Yoon J, Ko Y, Kim S, Cho S, Kim W, Park J, Youn H, Kim J, Lee B. Glycogen synthase kinase-3β does not correlate with the expression and activity of β-catenin in gastric cancer: GSK-3β AND β-CATENIN IN GASTRIC CANCER. APMIS 2010;118:782-90. [DOI: 10.1111/j.1600-0463.2010.02659.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
102 Lee HS, Choe G, Kim WH, Kim HH, Song J, Park KU. Expression of Lewis antigens and their precursors in gastric mucosa: relationship with Helicobacter pylori infection and gastric carcinogenesis. J Pathol 2006;209:88-94. [PMID: 16456898 DOI: 10.1002/path.1949] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
103 Bakkar RM, Xie S, Urbauer DL, Djordjevic B, Vu K, Broaddus RR. Intact PTEN Expression by Immunohistochemistry is Associated With Decreased Survival in Advanced Stage Ovarian/Primary Peritoneal High-grade Serous Carcinoma: . International Journal of Gynecological Pathology 2015;34:497-506. [DOI: 10.1097/pgp.0000000000000205] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
104 Lu W, Cao Y, Zhang Y, Li S, Gao J, Wang XA, Mu J, Hu YP, Jiang L, Dong P, Gong W, Liu Y. Up-regulation of PKM2 promote malignancy and related to adverse prognostic risk factor in human gallbladder cancer. Sci Rep 2016;6:26351. [PMID: 27283076 DOI: 10.1038/srep26351] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
105 Kim B, Byun SJ, Kim YA, Kim JE, Lee BL, Kim WH, Chang MS. Cell cycle regulators, APC/beta-catenin, NF-kappaB and Epstein-Barr virus in gastric carcinomas. Pathology. 2010;42:58-65. [PMID: 20025482 DOI: 10.3109/00313020903356392] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
106 Risinger JI, Custer M, Feigenbaum L, Simpson RM, Hoover SB, Webster JD, Chandramouli GV, Tessarollo L, Barrett JC. Normal viability of Kai1/Cd82 deficient mice. Mol Carcinog 2014;53:610-24. [PMID: 23401136 DOI: 10.1002/mc.22009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
107 Rodriguez-Pinilla M, Rodriguez-Peralto JL, Hitt R, Sanchez JJ, Sanchez-Verde L, Alameda F, Ballestin C, Sanchez-Cespedes M. beta-Catenin, Nf-kappaB and FAS protein expression are independent events in head and neck cancer: study of their association with clinical parameters. Cancer Lett 2005;230:141-8. [PMID: 16253770 DOI: 10.1016/j.canlet.2004.12.045] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
108 Shou ZX, Jin X, Zhao ZS. Upregulated expression of ADAM17 is a prognostic marker for patients with gastric cancer. Ann Surg. 2012;256:1014-1022. [PMID: 22668812 DOI: 10.1097/sla.0b013e3182592f56] [Cited by in Crossref: 38] [Cited by in F6Publishing: 27] [Article Influence: 4.2] [Reference Citation Analysis]
109 Luo W, Chen X, Li S, Wu A, Yao K. Neoplastic spindle cells in nasopharyngeal carcinoma show features of epithelial-mesenchymal transition: Nasopharyngeal carcinoma and EMT. Histopathology 2012;61:113-22. [DOI: 10.1111/j.1365-2559.2012.04205.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
110 Zhang JF, Zhang YP, Hao FY, Zhang CX, Li YJ, Ji XR. DNA ploidy analysis and expression of MMP-9, TIMP-2, and E-cadherin in gastric carcinoma. World J Gastroenterol 2005; 11(36): 5592-5600 [PMID: 16237750 DOI: 10.3748/wjg.v11.i36.5592] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
111 Yoon J, Ko YS, Cho SJ, Park J, Choi YS, Choi Y, Pyo JS, Ye SK, Youn HD, Lee JS, Chang MS, Kim MA, Lee BL. Signal transducers and activators of transcription 3-induced metastatic potential in gastric cancer cells is enhanced by glycogen synthase kinase-3β. APMIS 2015;123:373-82. [PMID: 25846563 DOI: 10.1111/apm.12370] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
112 Wang YY, Li L, Zhao ZS, Wang YX, Ye ZY, Tao HQ. L1 and epithelial cell adhesion molecules associated with gastric cancer progression and prognosis in examination of specimens from 601 patients. J Exp Clin Cancer Res. 2013;32:66. [PMID: 24422715 DOI: 10.1186/1756-9966-32-66] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
113 Nam SY, Ko YS, Jung J, Yoon J, Kim YH, Choi YJ, Park JW, Chang MS, Kim WH, Lee BL. A hypoxia-dependent upregulation of hypoxia-inducible factor-1 by nuclear factor-κB promotes gastric tumour growth and angiogenesis. Br J Cancer. 2011;104:166-174. [PMID: 21119667 DOI: 10.1038/sj.bjc.6606020] [Cited by in Crossref: 63] [Cited by in F6Publishing: 65] [Article Influence: 5.3] [Reference Citation Analysis]
114 Zhang Q, Ye Z, Yang Q, He X, Wang H, Zhao Z. Upregulated expression of annexin II is a prognostic marker for patients with gastric cancer. World J Surg Oncol. 2012;10:103. [PMID: 22681645 DOI: 10.1186/1477-7819-10-103] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
115 Kim MA, Jung EJ, Lee HS, Lee HE, Jeon YK, Yang HK, Kim WH. Evaluation of HER-2 gene status in gastric carcinoma using immunohistochemistry, fluorescence in situ hybridization, and real-time quantitative polymerase chain reaction. Hum Pathol 2007;38:1386-93. [PMID: 17555797 DOI: 10.1016/j.humpath.2007.02.005] [Cited by in Crossref: 83] [Cited by in F6Publishing: 74] [Article Influence: 5.5] [Reference Citation Analysis]
116 Zhao P, Liu W, Lu YL. Loss of fragile histidine triad protein expression and its clinicopathological significance in gastric cancer. Shijie Huaren Xiaohua Zazhi 2004; 12(3): 516-519 [DOI: 10.11569/wcjd.v12.i3.516] [Reference Citation Analysis]
117 Hwang JE, Shim HJ, Park YK, Cho SH, Bae WK, Kim DE, Kim KK, Chung IJ. Intravenous KITENIN shRNA injection suppresses hepatic metastasis and recurrence of colon cancer in an orthotopic mouse model. J Korean Med Sci 2011;26:1439-45. [PMID: 22065899 DOI: 10.3346/jkms.2011.26.11.1439] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
118 Barchi LC, Yagi OK, Jacob CE, Mucerino DR, Ribeiro U, Marrelli D, Roviello F, Cecconello I, Zilberstein B. Predicting recurrence after curative resection for gastric cancer: External validation of the Italian Research Group for Gastric Cancer (GIRCG) prognostic scoring system. Eur J Surg Oncol. 2016;42:123-131. [PMID: 26365755 DOI: 10.1016/j.ejso.2015.08.164] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
119 Qin J, Wang S, Shi J, Ma Y, Wang K, Ye H, Zhang X, Wang P, Wang X, Song C, Dai L, Wang K, Jiang B, Zhang J. Using recursive partitioning approach to select tumor-associated antigens in immunodiagnosis of gastric adenocarcinoma. Cancer Sci 2019;110:1829-41. [PMID: 30950146 DOI: 10.1111/cas.14013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
120 Park YS, Jin MY, Kim YJ, Yook JH, Kim BS, Jang SJ. The global histone modification pattern correlates with cancer recurrence and overall survival in gastric adenocarcinoma. Ann Surg Oncol. 2008;15:1968-1976. [PMID: 18470569 DOI: 10.1245/s10434-008-9927-9] [Cited by in Crossref: 120] [Cited by in F6Publishing: 100] [Article Influence: 8.6] [Reference Citation Analysis]
121 Zhang J, Zhou Y, Tang PMK, Cheng ASL, Yu J, To KF, Kang W. Mechanotransduction and Cytoskeleton Remodeling Shaping YAP1 in Gastric Tumorigenesis. Int J Mol Sci 2019;20:E1576. [PMID: 30934860 DOI: 10.3390/ijms20071576] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
122 Suh YS, Lee HJ, Jung EJ, Kim MA, Nam KT, Goldenring JR, Yang HK, Kim WH. The combined expression of metaplasia biomarkers predicts the prognosis of gastric cancer. Ann Surg Oncol. 2012;19:1240-1249. [PMID: 22048633 DOI: 10.1245/s10434-011-2125-1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 2.5] [Reference Citation Analysis]
123 Sereno M, De Castro J, Cejas P, García-Cabezas MA, Belda C, Casado E, Feliu J, Gómez C, López M, Barón MG. Expression profile as predictor of relapse after adjuvant treatment in gastric cancer. J Gastrointest Cancer. 2012;43:181-189. [PMID: 21360269 DOI: 10.1007/s12029-011-9267-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
124 Lee HS, Lee HE, Park DJ, Kim HH, Kim WH, Park KU. Clinical significance of serum and tissue Dickkopf-1 levels in patients with gastric cancer. Clin Chim Acta 2012;413:1753-60. [PMID: 22796372 DOI: 10.1016/j.cca.2012.07.003] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
125 Ko YS, Cho SJ, Park J, Kim Y, Choi YJ, Pyo JS, Jang BG, Park JW, Kim WH, Lee BL. Loss of FOXO1 promotes gastric tumour growth and metastasis through upregulation of human epidermal growth factor receptor 2/neu expression. Br J Cancer. 2015;113:1186-1196. [PMID: 26448177 DOI: 10.1038/bjc.2015.273] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
126 Li K, Du H, Lian X, Chai D, Li X, Yang R, Wang C. Establishment and characterization of a metastasis model of human gastric cancer in nude mice. BMC Cancer 2016;16:54. [PMID: 26847082 DOI: 10.1186/s12885-016-2101-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
127 Qian X, Zhang W, Yang H, Zhang L, Kang N, Lai J. Role of Yes-associated Protein-1 in Gastrointestinal Cancers and Hepatocellular Carcinoma. Explor Res Hypothesis Med 2021;6:110-7. [PMID: 34589656 DOI: 10.14218/ERHM.2021.00017] [Reference Citation Analysis]